INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE)

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / BIOTECHNOLOGY
Total 13F shares
60,795
Share change
+3,467
Total reported value
$5,003,054
Price per share
$82.15
Number of holders
12
Value change
+$323,746
Number of buys
7
Number of sells
3

Institutional Holders of INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) as of Q4 2025

As of 31 Dec 2025, INVESCO EXCHANGE TRADED FD T - BIOTECHNOLOGY (PBE) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 60,795 shares. The largest 10 holders included YHB Investment Advisors, Inc., Newman Dignan & Sheerar, Inc., FLAGSHIP HARBOR ADVISORS, LLC, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, SIGNET FINANCIAL MANAGEMENT, LLC, Archford Capital Strategies, LLC, Stratos Wealth Partners, LTD., Sowell Financial Services LLC, BOS Asset Management, LLC, and HARBOR INVESTMENT ADVISORY, LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.